home / stock / axim / axim news

AXIM News and Press, Axim Biotechnologies Inc From 06/05/19

Stock Information
Company Name: Axim Biotechnologies Inc
Stock Symbol: AXIM
Market: OTC
Website: aximbiotech.com
Menu
AXIM AXIM Quote AXIM Short AXIM News AXIM Articles AXIM Message Board
Get AXIM Alerts

News, Short Squeeze, Breakout and More Instantly...
AXIM - FOX Business Features Opinion Article Authored by AXIM Biotechnologies, Inc. CEO on Why Legal CBD is Good for Consumers and the Economy

NEW YORK, June 05, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has garnered news c...
AXIM - AXIM® Biotechnologies, Inc. Signs Cannabinoid Product Supply Agreement with Healthcare Company for Clinical Trials on Treatment of Periodontitis

NEW YORK, June 03, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), a world leader in cannabinoid research and product development, today announced that it has signed a cannab...

AXIM - Medical Marijuana Is Undervalued At 3.2x Forward Sales

With Q1 revenue growing at 92% y/y and a gross profit of 78%, Medical Marijuana ( MJNA ) recently surprised the market. The quarterly results were beneficial, and the company is undervalued at 3.2x forward sales. Other competitors are trading at much higher valuations. If MJNA continues delive...

AXIM - Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing

Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing Cannastocks2019 Investor Conference & Webinar Now Available for On-Demand Viewing Canada NewsWire NEW YORK, May 17, 2019 Individual and institutional investors as well as advisors a...
AXIM - AXIM® Biotechnologies Announces Additional Purchase Order for Nutraceutical Product With Leading Direct Selling Company

NEW YORK, May 15, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “AXIM”, or the “Company”), a world leader in cannabinoid research and development, today announced that the company has received an ad...

AXIM - AXIM® Biotechnologies to Present at Cannastocks 2019 Q1 Conference

NEW YORK, May 14, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (OTC: AXIM) (“AXIM® Biotech”, “Axim”, or the “Company”), a world leader in cannabinoid research and development, today announced that the Company will be attendin...

AXIM - Medical Marijuana, Inc. Major Investment Company Axim® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

NEW YORK , May 14, 2019 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that the Company's major investment company AXIM® Biotechnologies, Inc. (OTC: AXIM) ("AXIM"), a world l...
AXIM - Cannastocks2019 Live-Stream Investor Conference & Webinar May 15th

NEW YORK , May 14, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with Midtown Partners & Co, LLC, today announced the agenda for the upcoming Cannastocks2019 Q1 Virtual lnvestor Conference. Individual investors, institutional investors, advisors, and analysts are i...

AXIM - AXIM® Biotechnologies Files New U.S. Provisional Patent for Cannabis Gum as a Treatment for Migraine Symptoms

NEW YORK, May 09, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced that the Company has filed a provi...

AXIM - AXIM® Biotechnologies, Inc. Nutraceutical Division Receives Purchase Order for 50,000 Boxes of the Company's Proprietary CBD-Based Chewing Gum

NEW YORK, April 23, 2019 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM ® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced that the nutraceutical...
Previous 10 Next 10